SCHEMBL4884889

SCHEMBL4884889

CN(C)C(=O)CCCCC(C)(C)c1cccc(O)c1

nearest known ligand 0.41

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 13/20 0.41
CNR2 P34972 12/20 0.39
ALOX5 P09917 1/20 0.36
HSD17B1 P14061 1/20 0.36
HSD17B2 P37059 1/20 0.36
KIF11 P52732 1/20 0.36
TBXAS1 P24557 1/20 0.36
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPK1 P28482 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14025159 0.85 CNR1 (0.53) CNR1CNR2
SCHEMBL4888686 0.83 CNR2 (0.47) CNR1CNR2ALOX5
SCHEMBL6156319 0.80 ESR1 (0.45) CNR1CNR2HSD17B1HSD17B2KIF11
SCHEMBL4888766 0.78 CNR1 (0.46) CNR1CNR2MEN1ALDH1A1MAPK1
SCHEMBL10411509 0.78 ESR1 (0.46) CNR1CNR2MEN1ALDH1A1MAPK1
SCHEMBL3855592 0.77 CNR2 (0.57) CNR1CNR2
SCHEMBL11164590 0.76 CNR2 (0.59) CNR1CNR2
SCHEMBL4881841 0.76 CNR2 (0.59) CNR1CNR2
SCHEMBL10922725 0.76 CNR2 (0.59) CNR1CNR2
SCHEMBL11160476 0.76 CNR2 (0.59) CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080262011-A1 Modulator UCL BIOMEDICA PLC (GB) 2008-10-23 US disclosed
US-20080262011-A1 Modulator UCL BIOMEDICA PLC (GB) 2008-10-23 US disclosed
US-20080262011-A1 Modulator UCL BIOMEDICA PLC (GB) 2008-10-23 US disclosed
EP-1853538-A2 MODULATOR UCL Biomedica plc (GB) 2007-11-14 EP disclosed
WO-2006067450-A2 MODULATOR UCL BIOMEDICA PLC (GB) 2006-06-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080262011-A1 Modulator CHRNA10, CNR1, CHRNA9 CNR1 2/4885CNR2 12/4885ALOX5 780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.